Related Experiment Video
Updated: Jan 9, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.9K
Exploring Parkinson's Disease Datasets: Key Findings, Challenges, and Recommendations for Motor Symptom Analysis.
Summary
This study reviews 17 Parkinson's Disease (PD) datasets for motor symptom analysis. It highlights challenges in accessibility and data variability for machine learning applications in PD.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Data Science
Background:
- Parkinson's Disease (PD) is a neurodegenerative disorder with characteristic motor symptoms like bradykinesia and tremor.
- Advancements in sensing technology have enabled data collection for PD motor symptom analysis.
- Machine Learning (ML) and Deep Learning (DL) show promise for early diagnosis and personalized treatment in PD.
Purpose of the Study:
- To survey widely used Parkinson's Disease motor symptom analysis datasets.
- To examine dataset features, modalities, and data sources.
- To address challenges related to dataset variability and accessibility.
Main Methods:
- Systematic review of 17 prominent Parkinson's Disease motor symptom datasets.
- Analysis of dataset characteristics including features, data collection methods, and patient populations.
- Identification of common challenges and limitations across datasets.
Main Results:
- Compilation of key features and modalities from 17 PD motor symptom datasets.
- Identification of significant variability in data collection and features across datasets.
- Highlighting challenges in patient accessibility and dataset availability for research.
Conclusions:
- Standardization of datasets is crucial for advancing ML/DL applications in Parkinson's Disease.
- Addressing data accessibility and variability will facilitate cross-dataset studies and wider implementation.
- Further research is needed to overcome current limitations in PD dataset utilization.
Related Concept Videos
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945

